| pubmed-article:12165310 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12165310 | lifeskim:mentions | umls-concept:C0038340 | lld:lifeskim |
| pubmed-article:12165310 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:12165310 | lifeskim:mentions | umls-concept:C0004340 | lld:lifeskim |
| pubmed-article:12165310 | lifeskim:mentions | umls-concept:C0003455 | lld:lifeskim |
| pubmed-article:12165310 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:12165310 | pubmed:dateCreated | 2002-8-7 | lld:pubmed |
| pubmed-article:12165310 | pubmed:abstractText | We investigated ant sting related fatalities in Australia over the period 1980-1999. Data was obtained from the Australian Bureau of Statistics and state coronial authorities. Six ant sting-related fatalities were identified, five in Tasmania and one in New South Wales. All were males aged between 40 and 80-years-of-age and most (5/6) had prior histories of jumper or bull ant (Myrmecia spp.) venom allergy. However, none of the deceased carried injectable adrenaline and most died within 20 min of a single sting. Significant cardiopulmonary co-morbidities were identified in all cases and, in addition, moderate-severe laryngeal oedema and coronary atherosclerosis was observed in most (4/6) cases at autopsy. Where ascertained, Myrmecia ant venom specific immunoglobulin E antibodies levels were always elevated and fell into two distinct patterns of immunoreactivity. Adult Tasmanian males with a prior history of ant venom allergy and cardiopulmonary co-morbidities are therefore at highest risk of a fatal outcome from ant stings. Deaths may be avoided by the early recognition of anaphylaxis and self-treatment with adrenaline as well as by the development of purified Myrmecia ant venom immunotherapy. | lld:pubmed |
| pubmed-article:12165310 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12165310 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12165310 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12165310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12165310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12165310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12165310 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12165310 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12165310 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12165310 | pubmed:issn | 0041-0101 | lld:pubmed |
| pubmed-article:12165310 | pubmed:author | pubmed-author:WinkelKenneth... | lld:pubmed |
| pubmed-article:12165310 | pubmed:author | pubmed-author:McGainForbesF | lld:pubmed |
| pubmed-article:12165310 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12165310 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:12165310 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12165310 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12165310 | pubmed:pagination | 1095-100 | lld:pubmed |
| pubmed-article:12165310 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:meshHeading | pubmed-meshheading:12165310... | lld:pubmed |
| pubmed-article:12165310 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12165310 | pubmed:articleTitle | Ant sting mortality in Australia. | lld:pubmed |
| pubmed-article:12165310 | pubmed:affiliation | Australian Venom Research Unit, Department of Pharmacology, University of Melbourne, Melbourne, 3010 Vic., Australia. | lld:pubmed |
| pubmed-article:12165310 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12165310 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
